PIOLAX (5988) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
12 Nov, 2026Executive summary
H1 FY2027 sales rose 6.4% YoY to ¥31,998 million; operating profit fell 12.5% to ¥739 million, while ordinary profit increased 14.2% to ¥899 million.
Profit attributable to owners declined 28.7% YoY to ¥310 million; comprehensive income was ¥1,856 million, versus a loss of ¥1,885 million a year earlier.
Financial highlights
Gross profit increased to ¥6,928 million from ¥6,606 million; SG&A rose to ¥6,188 million from ¥5,760 million.
Operating cash flow was ¥3,949 million, versus ¥1,474 million; investing cash flow was negative ¥373 million, versus negative ¥4,538 million.
Cash and cash equivalents ended the half at ¥24,649 million, compared with ¥21,396 million at the prior-year period end.
Total assets were ¥101,126 million at September 30, 2026, versus ¥101,415 million at March 31, 2026; net assets were ¥66,113 million.
Outlook and guidance
FY2027 forecast: net sales ¥63,000 million, operating profit ¥1,500 million, ordinary profit ¥1,500 million, and parent-attributable profit ¥700 million; forecasts unchanged.
Forecast basic EPS is ¥27.45; annual dividend forecast is ¥92 per share, with no revision to the dividend outlook.
Forward-looking estimates rely on available information and assumptions; actual results may differ due to various factors.
Latest events from PIOLAX
- Net sales rose 4.4% and comprehensive income turned positive, with modest growth forecasted.5988
Q1 2027 - FY2026 profit fell to a net loss; FY2027 guidance points to modest recovery.5988
Q4 2026 - Sales rose but profits fell on higher costs; full-year profit forecast remains lower.5988
Q1 2025 - Sales up 3.2% but profits down; focus on CASE, global growth, and capital returns.5988
Q2 2025 - Net income fell 52% year-over-year as sales and profitability declined, with guidance unchanged.5988
Q3 2025 - Profits and sales fell sharply, but long-term growth targets and strong shareholder returns remain.5988
Q4 2025 - Profits and comprehensive income fell sharply, with a cautious outlook for the full year.5988
Q1 2026 - Profits and sales fell sharply, prompting strategic focus on innovation and cost control.5988
Q2 2026 - Profits and comprehensive income fell sharply, but a moderate recovery is forecasted.5988
Q3 2026